SARTORIUS AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 222.8 EUR | -3.78% |
|
-0.67% | -16.04% |
| 11:06am | SARTORIUS VORZUEGE : UBS remains Neutral | ZD |
| 05-13 | Sartorius Partners With Sanofi for Biomanufacturing Platform | MT |
| Sales 2024 * | 3.57B 3.88B 307B | Sales 2025 * | 4.02B 4.37B 345B | Capitalization | 18.12B 19.7B 1,554B |
|---|---|---|---|---|---|
| Net income 2024 * | 213M 232M 18.28B | Net income 2025 * | 342M 372M 29.34B | EV / Sales 2024 * | 6.21 x |
| Net Debt 2024 * | 4.05B 4.41B 348B | Net Debt 2025 * | 3.82B 4.15B 328B | EV / Sales 2025 * | 5.46 x |
| P/E ratio 2024 * |
77.5
x | P/E ratio 2025 * |
54
x | Employees | 14,614 |
| Yield 2024 * |
0.29% | Yield 2025 * |
0.39% | Free-Float | 35.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sartorius AG
More press releases
More news
| 1 day | -3.78% | ||
| 1 week | -0.67% | ||
| Current month | +1.14% | ||
| 1 month | -13.93% | ||
| 3 months | -18.35% | ||
| 6 months | +3.49% | ||
| Current year | -16.04% |
1 week
218.00
235.00
1 month
204.00257.50
Current year
204.00290.00
1 year
181.00310.50
3 years
181.00834.00
5 years
138.50834.00
10 years
22.50834.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 30/04/99 | |
| Chief Tech/Sci/R&D Officer | 59 | 31/12/94 | |
Volker Niebel
COO | Chief Operating Officer | 67 | 31/12/00 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
BRD | Director/Board Member | 69 | 31/12/19 |
| Director/Board Member | 75 | 28/11/11 | |
| Director/Board Member | 58 | 05/04/17 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 391 M€ | +9.52% | - | |
| 0.00% | 34 M€ | +9.13% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/05/24 | 222.5 | -3.89% | 2 352 |
| 15/05/24 | 231.5 | +2.66% | 2,429 |
| 14/05/24 | 225.5 | +2.50% | 3,532 |
| 13/05/24 | 220 | -0.68% | 1,634 |
| 10/05/24 | 221.5 | -1.12% | 2,626 |
Delayed Quote Xetra, May 16, 2024 at 09:50 am
More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
09:00am
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
292.9
EUR
Average target price
329.2
EUR
Spread / Average Target
+12.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -39.00% | 3.01B | |
| +22.02% | 1.94B | |
| -0.62% | 1.66B | |
| +34.11% | 1.34B | |
| -22.01% | 895M | |
| +6.19% | 827M | |
| -23.80% | 638M | |
| +10.85% | 516M | |
| -.--% | 486M |
- Stock Market
- Equities
- SRT3 Stock
- SRT Stock
